Literature DB >> 16437731

Is colonoscopy sufficient for colorectal cancer surveillance in all HNPCC patients?

Vito D Corleto1, Ermira Zykaj, Paolo Mercantini, Emanuela Pilozzi, Michele Rossi, Antonella Carnuccio, Emilio Di Giulio, Vincenzo Ziparo, Gianfranco Delle Fave.   

Abstract

A 34-year-old male with hereditary non-polyposis colon cancer with a mutation in hMSH2 line is reported. Despite regular colonoscopic follow-up, he developed cecal cancer involving the extraluminal area. Due to sub-occlusive symptoms, the patient was submitted to further colonoscopy, however with no clear evidence of neoplasia. Thin slice multiplanar reconstruction computed tomography CT scan performed thereafter revealed a transmural mass 2.5 cm in size localized near the cecal valve. Discussion is made on the reliability of colonoscopic examinations as well as the need for further investigations in the follow-up of patients at very high risk of right-sided colon cancer, such as male hMSH2 carrier affected by hereditary non-polyposis colon cancer.

Entities:  

Mesh:

Year:  2005        PMID: 16437731      PMCID: PMC4725167          DOI: 10.3748/wjg.v11.i47.7541

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  19 in total

1.  The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer.

Authors:  W S Samowitz; K Curtin; H H Lin; M A Robertson; D Schaffer; M Nichols; K Gruenthal; M F Leppert; M L Slattery
Journal:  Gastroenterology       Date:  2001-10       Impact factor: 22.682

Review 2.  Testing guidelines for hereditary non-polyposis colorectal cancer.

Authors:  Asad Umar; John I Risinger; Ernest T Hawk; J Carl Barrett
Journal:  Nat Rev Cancer       Date:  2004-02       Impact factor: 60.716

3.  American Gastroenterological Association medical position statement: hereditary colorectal cancer and genetic testing.

Authors: 
Journal:  Gastroenterology       Date:  2001-07       Impact factor: 22.682

Review 4.  Hereditary nonpolyposis colorectal cancer.

Authors:  H T Lynch; J F Lynch
Journal:  Semin Surg Oncol       Date:  2000-06

5.  Microsatellite marker analysis in screening for hereditary nonpolyposis colorectal cancer (HNPCC).

Authors:  A Loukola; K Eklin; P Laiho; R Salovaara; P Kristo; H Järvinen; J P Mecklin; V Launonen; L A Aaltonen
Journal:  Cancer Res       Date:  2001-06-01       Impact factor: 12.701

6.  A prospective study of colonoscopy practice in the UK today: are we adequately prepared for national colorectal cancer screening tomorrow?

Authors:  C J A Bowles; R Leicester; C Romaya; E Swarbrick; C B Williams; O Epstein
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

7.  Colonoscopy surveillance of individuals at risk of familial colorectal cancer.

Authors:  N Bradshaw; S Holloway; I Penman; M G Dunlop; M E M Porteous
Journal:  Gut       Date:  2003-12       Impact factor: 23.059

Review 8.  Genetic testing for high-risk colon cancer patients.

Authors:  William M Grady
Journal:  Gastroenterology       Date:  2003-05       Impact factor: 22.682

Review 9.  Hereditary nonpolyposis colorectal cancer: preventive management.

Authors:  Hwei-Ju Annie Yu; Kevin M Lin; David M Ota; Henry T Lynch
Journal:  Cancer Treat Rev       Date:  2003-12       Impact factor: 12.111

10.  Cumulative incidence of colorectal and extracolonic cancers in MLH1 and MSH2 mutation carriers of hereditary nonpolyposis colorectal cancer.

Authors:  K M Lin; M Shashidharan; A G Thorson; C A Ternent; G J Blatchford; M A Christensen; P Watson; S J Lemon; B Franklin; B Karr; J Lynch; H T Lynch
Journal:  J Gastrointest Surg       Date:  1998 Jan-Feb       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.